This Practice Note is intended to be used to Track the progress of UK cases relevant to the life sciences Sector.
Jump to:
- •
Judgments—Patents
- •
Judgments—Supplementary protection certificates
- •
Judgments—Medical devices and medicinal products
- •
Judgments—Trade marks
For archived items on life sciences, see Practice Note: Life sciences tracker [Archived].
For a discussion on the extent to which UK courts and tribunals are bound by EU case law after the end of the transition period, see Q&A: Are UK courts and tribunals bound by decisions of the Court of Justice of the European Union post-Brexit?
Judgments—Patents
For archived patents judgments, see Practice Note: Life sciences tracker [Archived]—Judgments—Patents.
Supreme Court
What's happening? | When? | Find out more |
UKSC 2021/0209Appeal from:FibroGen Inc v Akebia Therapeutics Inc; Astellas Pharma Inc v Akebia Therapeutics Inc[2021] EWCA Civ 1279 | March 2024: Supreme Court hearing3 October 2022: Permission to appeal granted by the Supreme Court24 August 2021: Judgment of the Court of Appeal delivered20 April 2020: Judgment of the Patents Court delivered | Plausibility and undue |
To view the latest version of this document and thousands of others like it,
sign-in with LexisNexis or register for a free trial.